Terms ending in 2036
Every in-force patent on Givaudan S.A.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,066,219 | Thioesterases and Their Use In force · High confidence | Utah State University | In force | High confidence | |
| US 10,980,262 | Barrier Layer Capsules In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 11,102,991 | Encapsulation In force · Medium confidence | Givaudan S.A. | In force | Medium confidence | |
| US 10,633,314 | Method for the Conversion of Abienol to Sclarediol In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 11,639,484 | Perfume Compositions In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 10,294,211 | Process for Isolating and Purifying Ambrox In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 10,472,655 | Enzymes and Applications Thereof In force · High confidence | Proteus S.A. | In force | High confidence | |
| US 11,021,722 | Enzymes and Applications Thereof In force · High confidence | Proteus S.A. | In force | High confidence | |
| US 11,466,299 | Enzymes and Applications Thereof In force · High confidence | Proteus S.A. | In force | High confidence | |
| US 12,071,645 | Enzymes and Applications Thereof In force · High confidence | Givaudan S.A. | In force | High confidence | |
| 7 more term ends in 2036 · Pro | |||||
10 of 17 patents shown. Soonest term end first, then patent number.
Pro members see all 17.
13 of these are in force and held by Givaudan S.A..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.